Ketamine and Postoperative Analgesia in Children
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2005 by Nantes University Hospital.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Nantes University Hospital
Information provided by:
Nantes University Hospital
ClinicalTrials.gov Identifier:
NCT00200564
First received: September 12, 2005
Last updated: October 22, 2007
Last verified: July 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The benefit of small doses of ketamine has been demonstrated for postoperative analgesia in adults but remains unproved in children. The investigators' purpose is to evaluate the effects of continuous intravenous small doses of ketamine versus placebo to improve the quality of postoperative analgesia in children (6 months to 6 years of age). Caudal anesthesia is performed for intraoperative analgesia and all children receive paracetamol, a non-steroidal anti-inflammatory and continuous intravenous nalbuphine.
| Condition | Intervention | Phase |
|---|---|---|
|
Postoperative Analgesia |
Drug: ketamine |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind |
| Official Title: | Ketamine and Postoperative Analgesia in Children |
Resource links provided by NLM:
Further study details as provided by Nantes University Hospital:
Primary Outcome Measures:
- Area under the curve of pain scores (CHEOPS) measured [ Time Frame: every 2 hours during the first 24 hours after eyes open ]
Secondary Outcome Measures:
- Evaluation by the parents and nurses of the quality of analgesia with a visual analogue scale graded from 0 to 10 [ Time Frame: at the 24th hour ]
- Number of painful episodes requiring additional boluses of nalbuphine
- Number of children requiring morphine after inefficiency of additional boluses of nalbuphine
- Percentage of children with side effects related to injection of ketamine
- Time to complete feeding
- Percentage of children with nausea or vomiting
| Estimated Enrollment: | 74 |
| Study Start Date: | February 2004 |
Eligibility| Ages Eligible for Study: | 6 Months to 6 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Children between 6 months to 6 years of age
- American Society of Anesthesiologists (ASA) I or II
- Undergoing elective surgery with intraoperative caudal analgesia
Exclusion Criteria:
- ASA III or IV
- Contraindication to caudal anesthesia
- Allergy to drugs used in the study
- Failure in caudal puncture
- Administration of morphine derivative
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00200564
Contacts
| Contact: Véronique Bazin, MD | 00 33 2 40 08 35 47 | veronique.bazin@chu-nantes.fr |
Locations
| France | |
| Nantes University Hospital | Recruiting |
| Nantes, France, 44093 | |
| Contact: Véronique Bazin, MD 00 33 2 40 08 35 47 veronique.bazin@chu-nantes.fr | |
Sponsors and Collaborators
Nantes University Hospital
Investigators
| Principal Investigator: | Véronique Bazin, MD | Nantes UH |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00200564 History of Changes |
| Other Study ID Numbers: | BRD/03/12-H |
| Study First Received: | September 12, 2005 |
| Last Updated: | October 22, 2007 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Nantes University Hospital:
|
Pediatrics ketamine postoperative analgesia nalbuphine Postoperative analgesia in children |
Additional relevant MeSH terms:
|
Ketamine Anesthetics, Dissociative Anesthetics, Intravenous Anesthetics, General Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents |
Therapeutic Uses Excitatory Amino Acid Antagonists Excitatory Amino Acid Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Analgesics Sensory System Agents Peripheral Nervous System Agents |
ClinicalTrials.gov processed this record on May 19, 2013